Peripheral Arterial Disease Clinical Trials in New York, New York

4 studies are recruiting for peripheral arterial disease in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

    The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for…

    Stage
    Not phased
    Ages
    22 and older
    Site
    Mount Sinai, New York, New York
    Locations
    4 in total
    Run by
    Medtronic Endovascular

    See if you can join NCT07335341 on ClinicalTrials.gov

  2. The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

    The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

    Stage
    Not phased
    Ages
    18 and older
    Site
    New York University School of Medicine, New York, New York
    Locations
    43 in total
    Run by
    W.L.Gore & Associates

    See if you can join NCT05811364 on ClinicalTrials.gov

  3. SELUTION4BTK Trial

    This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Sorin Medical Group, New York, New York
    Locations
    48 in total
    Run by
    M.A. Med Alliance S.A.

    See if you can join NCT05055297 on ClinicalTrials.gov

  4. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

    A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

    Stage
    Not phased
    Ages
    18 to 95
    Site
    NYU Langone Health, New York, New York
    Locations
    30 in total
    Run by
    LimFlow, Inc.

    See if you can join NCT05313165 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.